Fish Oil in Rheumatic Diseases

Rheumatic Disease Clinics of North America

Volumn 37, Issue 1, 2011, Pages 77-84

  Bhangle, Samir ^a   Kolasinski, Sharon L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anti inflammatory; Arachidonic acid; Fish oil; Polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; BLEEDING; CEREBROVASCULAR ACCIDENT; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; FAT INTAKE; FATTY ACID ANALYSIS; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTRIGLYCERIDEMIA; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TASTE DISORDER;

ANTI-INFLAMMATORY AGENTS; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHEUMATIC DISEASES; TREATMENT OUTCOME;

EID: 78650942450     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.11.003     Document Type: Review

References (51)

1. Kronmann N., Green A. Epidemiological studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950-1974. Acta Med Scand 1980, 208:401-406.
2. Simopoulos A.P. N-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991, 54:438-463.
3. Proudman S.M., Cleland L.G., James M.J. Dietary omega-3 fats for the treatment of inflammatory joint disease: efficacy and utility. Rheum Dis Clin North Am 2008, 34:469-479.
4. Salmmon J.A., Higgs G.A. Prostaglandins and leukotrienes as inflammatory mediators. Br Med Bull 1987, 43:285-296.
5. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983, 220:568-575.
6. Caughey G.E., Pouliot M., Cleland L.G., et al. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in non-adherent human monocytes. J Immunol 1997, 158:351-358.
7. Mantzioris E., Cleland L.G., Gibson R.A., et al. Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am J Clin Nutr 2000, 72:42-48.
8. Caughey G.E., mantzoris E., Gibson R.A., et al. The effect on human tumor necrosis factor alpha and interleukin-1 beta of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996, 63:116-122.
9. Endres S., Ghorbani R., Kelley V.E., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265-271.
10. Meydani S.N., Endres S., Woods M.M., et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991, 121:547-555.
11. Sun Y.P., Oh S.F., Gronert K., et al. Resolvin D1 and its aspirin-triggered 17 R epimer: stereoisomer assignments, anti-inflammatory properties, and enzymic inactivation. J Biol Chem 2007, 282:9323-9334.
12. Serhan C.N., Hong S., Gronert K., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196:1025-1037.
13. Hughes D.A., Southon S., Pinder A. (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 1996, 126:603-610.
14. Hughes D.A., Pinder A.C. (n-3) Polyunsaturated fatty acids inhibit the antigen-presenting function of human monocytes. Am J Clin Nutr 2000, 71:357S-360S.
15. Hughes D.A., Pinder A.C., Piper Z., et al. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 1996, 63:267-272.
16. Liao H.-X., Haynes B.F. Role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am 1995, 21:715-740.
17. Kavanagh A.F., Davis L.S., Nichols L., et al. Treatment of rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 1994, 37:992-999.
18. Curtis C., Rees S., Little C., et al. Pathological indicators of degradation and inflammation in human osteoarthritis cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum 2002, 46:1544-1553.
19. Curtis C., Hughes C., Flannery C., et al. n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 2000, 275:721-724.
20. Stamp L., James M., Cleland L. Diet and rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 2005, 35:77-94.
21. Cleland L.G., James J.M., Proudman S.M. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003, 9:845-853.
22. Fortin P.R., Lew R.A., Liang M.H., et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 1995, 48:1379-1390.
23. Goldberg R.J., Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007, 129:210-223.
24. Skoldstam L., Borjesson O., Kjallman A., et al. Effects of six months of fish oil supplementation in stable rheumatoid arthritis. A double blind, controlled study. Scand J Rheumatol 1992, 21:178-185.
25. Lau C.S., Morley K.D., Belch J.J. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis-a double blind placebo controlled study. Br J Rheumatol 1993, 32:982-989.
26. Geusens P., Wouters C., Nijs J., et al. Long term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum 1994, 37:824-829.
27. Kremer J.M., Lawrence D.A., Petrillo G.F., et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1995, 38:1107-1114.
28. Kjeldsen-Kragh J., Lund J.A., Riise T., et al. Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis. J Rheumatol 1992, 19:1531-1536.
29. Kremer J.M., Lawrence D.A., Jubiz W., et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arthritis Rheum 1990, 33:810-819.
30. Pestka J.J. n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis. Prostaglandins Leukot Essent Fatty Acids 2010, 82(4-6):251-258.
31. Donadio J.V. The emerging role of omega-3 polyunsaturated fatty acids in the management of patients with IgA nephropathy. J Ren Nutr 2001, 11:122-128.
32. Duffy E.M., Meenagh G.K., McMillan S.A., et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol 2004, 8:1551-1556.
33. Belluzzi A., Brignola C., Campieri M., et al. Effect of an enteric-coated fish-oil preparation on relapses on crohn's disease. N Engl J Med 1996, 334:1557-1560.
34. Harris W.S., Ginsberg S.N., Arunakul N., et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997, 4:385-391.
35. Howe P.R. Dietary fats and hypertension. Focus on fish oil. Ann N Y Acad Sci 1997, 827:339-352.
36. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
37. Von Schacky C., Angerer P., Kothny W., et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double blind, placebo controlled trial. Ann Intern Med 1999, 130:554-562.
38. Zochling J., March L.M., Lapsley H., et al. Use of complementary medicines for osteoarthritis-a prospective study. Ann Rheum Dis 2004, 63:549-554.
39. Jordan K.M., Sawyer S., Coakley P., et al. The use of conventional and complementary treatments for knee osteoarthritis in the community. Rheumatology 2004, 43:381-384.
40. Stammers T., Sibbald B., Freeling P. Efficacy of cod liver oil as an adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general. Ann Rheum Dis 1992, 51:128-129.
41. Zainal Z., Longman A.J., Hurst S., et al. Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthritis Cartilage 2009, 17:896-905.
42. Wnag Y., Wluka A.E., Hodge A.M., et al. Effect of fatty acids on bone marrow lesions and knee cartilage in healthy middle-aged subjects without clinical knee osteoarthritis. Osteoarthritis Cartilage 2008, 16:579-583.
43. Roush J.K., Cross A.R., Renberg W.C., et al. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. J Am Vet Med Assoc 2010, 236(1):67-73.
44. Cleland L.G., Proudman S.M., Hall C., et al. A biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids 2003, 38:419-424.
45. Cleland L.G., Caughey G.E., James M.J., et al. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. J Rheumatol 2006, 33:1973-1979.
46. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455.
47. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65:1645S-1654S.
48. Eritsland J., Arnesen H., Gronseth K., et al. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996, 77:31-36.
49. Montori V., Farmer A., Wollan P., et al. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 2000, 23:1217-1218.
50. Department of Health and Human Services US Food and Drug Administration. Substances affirmed as generally recognized as safe: menhaden oil. Fed Regist 1997, 62:30751-30757.
51. Office of Nutritional Products Labeling, and dietary supplements, center for food safety and applied nutrition 2002, US Food and Drug Administration, Available at:, Accessed November 8, 2010. http://www.fda.gov/AboutFDA/CentersOffices/OrganizationCharts/ucm135675.htm.